Results 11 to 20 of about 31,301 (241)

Postoperative irradiation for squamous cell carcinoma of head and neck: Retrospective comparison of accelerated radiochemotherapy and standard radiotherapy [PDF]

open access: yes, 2000
Background: Comparison of accelerated radiochemotherapy (aRCT) and standard radiotherapy (sRT) in postoperative treatment after macroscopically complete resection of squamous cell cancers of head and neck.
Kiszel, Z.   +8 more
core   +2 more sources

The role of the chemokine receptor CXCR4 in oral squamous cell carcinoma metastasis [PDF]

open access: yes, 2010
PhDOral Squamous Cell Carcinoma (OSCC) is the sixth most common cancer worldwide. The greatest cause of mortality and surgical morbidity is due to the common spread of tumour cells from the primary lesion to the lymph nodes of the neck. This pathway is
Collier, Jonathan Marc
core   +4 more sources

Human Papilloma Virus (HPV) Induced Head & Neck Squamous Cell Carcinoma: A Comprehensive Retrospect [PDF]

open access: yesJournal of Clinical and Diagnostic Research, 2015
Head and Neck Squamous Cell Carcinoma accounts for the sixth most common malignancy occurring worldwide with tobacco and alcohol being the two well established risk factors.
Roquaiya Nishat   +4 more
doaj   +1 more source

Cutaneous Squamous Cell Carcinoma of the Head and Neck [PDF]

open access: yesJournal of Skin Cancer, 2011
Cutaneous squamous cell carcinoma of the head and neck is an epidemic that reaches all parts of the world. Making the diagnosis relies on the acumen of the clinician and pathologist. Various pathologic subtypes exist and differ in histology and prognosis.
Vivek V. Gurudutt, Eric M. Genden
openaire   +3 more sources

A new concurrent chemotherapy with vinorelbine and mitomycin C in combination with radiotherapy in patients with locally advanced squamous cell carcinoma of the head and neck [PDF]

open access: yes, 2005
Objective: The purpose of this pilot study was to evaluate the feasibility and toxicity of concurrent chemotherapy with vinorelbine and mitomycin C in combination with accelerated radiotherapy (RT) in patients with locally advanced cancer of the head and
Wilkowski, R.   +5 more
core   +1 more source

Immunotherapy for squamous cell carcinoma of the head and neck [PDF]

open access: yesJapanese Journal of Clinical Oncology, 2020
Abstract Squamous cell carcinoma of the head and neck is characterized by an immunosuppressive environment and evades immune responses through multiple resistance mechanisms. A breakthrough in cancer immunotherapy employing immune checkpoint inhibitors has evolved into a number of clinical trials with antibodies against programmed cell ...
Tomoya Yokota   +19 more
openaire   +2 more sources

Immunotherapy for Head and Neck Squamous Cell Carcinoma [PDF]

open access: yesCurrent Oncology Reports, 2018
Discussion of current strategies targeting the immune system related to solid tumors with emphasis on head and neck squamous cell carcinoma (HNSCC).This review will outline the current challenges with immunotherapy and future goals for treatment using these agents.Agents targeting immune checkpoint receptors (IR) such as program death 1 (PD1) have been
Moskovitz, Jessica   +2 more
openaire   +2 more sources

Gene expression profiling of head and neck cancer [PDF]

open access: yes, 2004
MDThe purpose of this study was to classify oral squamous cell carcinomas (OSCCs) based on their gene expression profiles, to identify differentially expressed genes in these cancers, and to correlate genetic deregulation with clinical ...
Warner, Giles C
core   +4 more sources

Fibroblasts in head neck squamous cell carcinoma associated with perineural invasion have high level nuclear Yes-Associated Protein (YAP) expression [PDF]

open access: yes, 2015
Paul A. Reynolds, PhD, is supported by the Melville Trust for the Care and cure of Cancer.We retrospectively studied the expression of Yes-associated protein (YAP) using immunohistochemical staining in 10 cases of head and neck squamous cell carcinoma ...
Gersten, Adam   +5 more
core   +1 more source

Circulating tumor cells in head and neck cancer: A review

open access: yesWorld Journal of Otorhinolaryngology-Head and Neck Surgery, 2016
Carcinoma of the head and neck represents 3.5% of all cancers, and the vast majority of these tumors are squamous cell carcinoma (HNSCC). With a stable overall survival rate of 50% among all stages, there is continued interested in developing measures ...
Kyle P. McMullen   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy